Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Gene | JAK2 |
| Variant | rearrange |
| Impact List | unknown |
| Protein Effect | unknown |
| Gene Variant Descriptions | JAK2 rearrange indicates an unspecified rearrangement of the JAK2 gene. |
| Associated Drug Resistance | |
| Category Variants Paths |
JAK2 mutant JAK2 rearrange |
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT03801434 | Phase II | Ruxolitinib | Ruxolitinib in Treating Patients with Hypereosinophilic Syndrome or Primary Eosinophilic Disorders | Recruiting | USA | 0 |